ABRAXIS ONCOLOGY

pharmaceuticals for the treatment of cancer; pharmaceuticals, namely, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; nanoparticles for drug delivery or imaging agent delivery sold as an integral component of drugs or imaging agents